WANBURY
|
The Current P/B Ratio of WANBURY is 17.39.
Share Price | ₹314.2 | Jun 13,2025 |
Market Cap | ₹1,030.6 Cr | |
Book Value | ₹59.3 Cr | Mar2025 - Consolidated Results |
Price/Book | 17.39x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of WANBURY
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹1,030.6 Cr] as on Jun 13,2025
(/) Book Value [ ₹59.3 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 17.39x ]
Thus, for WANBURY , the investors are currently willing to pay '17.39 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of WANBURY !
The chart below summarizes the trend in P/B Ratio of WANBURY over the last five years.
Historical PB (Price/Book ) ratio chart of WANBURY
PB Ratio Performance Analysis for WANBURY
- WANBURY 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.24x.
- WANBURY 's operated at median p/b ratio of -1.33x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WANBURY 's p/b ratio peaked in Mar2024 at 22.63x.
- WANBURY 's p/b ratio hit its five-year low in Mar2022 of -11.25x.
How does WANBURY 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
WANBURY | 59.27 | 17.39 | 1,030.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.61 | 405,176.0 |
DIVIS LABORATORIES LTD | 14,969.00 | 11.83 | 177,076.0 |
CIPLA LTD | 31,193.40 | 3.90 | 121,592.0 |
TORRENT PHARMACEUTICALS LTD | 7,591.23 | 14.49 | 110,024.0 |
DR REDDYS LABORATORIES LTD | 33,549.60 | 3.39 | 113,615.0 |
MANKIND PHARMA LTD | 14,332.40 | 6.86 | 98,309.9 |
ZYDUS LIFESCIENCES LTD | 23,953.10 | 4.10 | 98,107.8 |
LUPIN LTD | 17,203.50 | 5.31 | 91,355.1 |
AUROBINDO PHARMA LTD | 32,653.30 | 2.05 | 66,829.9 |
ABBOTT INDIA LTD | 4,233.15 | 15.83 | 67,031.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs WANBURY 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.05x |
Max industry PB | 17.39x |
Median industry PB | 5.61x |
Average industry PB | 8.25x |
You may also like the below Video Courses